---
title: "Akzo Nobel Q2 Net Income Rises; On Track To Achieve FY Targets"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293425838.md"
description: "Akzo Nobel reported Q2 net income rose to €139 million from €124 million, with EPS at €0.81 vs €0.72 prior year. Adjusted EBITDA increased to €398 million. Revenue declined slightly to €2.59 billion, but organic sales grew 2%. The company remains on track for FY targets, expecting €100 million EBITDA improvement and a 2026 adjusted EBITDA of at least €1.47 billion. CEO Greg Poux-Guillaume confirmed the Axalta merger is progressing as planned."
datetime: "2026-07-22T05:45:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293425838.md)
  - [en](https://longbridge.com/en/news/293425838.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293425838.md)
---

# Akzo Nobel Q2 Net Income Rises; On Track To Achieve FY Targets

Add  as your preferred news source on Google

 Add Now

Akzo Nobel N.V. (AKZA.AS) reported that its second quarter profit to shareholders of the company increased to 139 million euros from 124 million euros, prior year. Earnings per share was 0.81 euros compared to 0.72 euros. Adjusted EBITDA increased to 398 million euros from 393 million euros. Organic adjusted EBITDA growth was 18 million euros, driven by pricing. Adjusted earnings per share from continuing operations was 1.07 euros compared to 1.13 euros. Second quarter revenue declined to 2.59 billion euros from 2.63 billion euros, last year. Organic sales growth was 2%, for the quarter.

Looking forward, the company expects to deliver 100 million euros of adjusted EBITDA improvement in constant currencies. Adjusted EBITDA for 2026 is expected to be at or above 1.47 billion euros, based on year-end 2025 exchange rates and adjusted for the India divestment. For the mid-term, AkzoNobel aims to expand profitability to deliver an adjusted EBITDA margin of above 16% and a return on investment between 16% and 19%.

CEO Greg Poux-Guillaume said: "Our merger with Axalta is progressing as planned, with the shareholder vote on August 5 and an expected closing at the end of 2026 or early 2027. And we remain on track to achieve our full-year targets."

At last close, Akzo Nobel shares were trading at 57.16 euros, down 0.45%.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

### Related Stocks

- [AXTA.US](https://longbridge.com/en/quote/AXTA.US.md)

## Related News & Research

- [AXTA: Record Q2 results with margin gains, robust cash flow, and progress on the AkzoNobel merger](https://longbridge.com/en/news/294050377.md)
- [Akzo Nobel Q2 2026 Results Show Margin Gains Amid Revenue Pressure and Axalta Merger Plans](https://longbridge.com/en/news/293502616.md)
- [Axalta Q2 sales and adjusted EPS beat estimates on acquisitions](https://longbridge.com/en/news/294046791.md)
- [Galp 2Q26 RCA EBITDA rises 52% to €1.27 billion; RCA net income climbs 45% to €540 million](https://longbridge.com/en/news/293885503.md)
- [DSM-Firmenich H1 FY26 adjusted EBITDA rises 7% LFL to EUR 900 million](https://longbridge.com/en/news/294307278.md)